Search Results - "Panoutsopoulou, Konstantina"

Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome by Pilala, Katerina-Marina, Papadimitriou, Maria-Alexandra, Panoutsopoulou, Konstantina, Barbarigos, Petros, Levis, Panagiotis, Kotronopoulos, Georgios, Stravodimos, Konstantinos, Scorilas, Andreas, Avgeris, Margaritis

“…Owing to its highly heterogeneous molecular landscape, bladder cancer (BlCa) is still characterized by non-personalized treatment and lifelong surveillance…”
Get full text

Cancer quiescence: non-coding RNAs in the spotlight by Soureas, Konstantinos, Papadimitriou, Maria-Alexandra, Panoutsopoulou, Konstantina, Pilala, Katerina-Marina, Scorilas, Andreas, Avgeris, Margaritis

“…Cancer quiescence is defined as a dynamic and reversible slow-cycling or mitotically arrested cell state, serving as the hallmark of cancer dormancy.Cancer…”
Get full text

Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer by Panoutsopoulou, Konstantina, Liu, Yueyang, Avgeris, Margaritis, Dreyer, Tobias, Dorn, Julia, Magdolen, Viktor, Scorilas, Andreas

“…•miR-146a repression is associated with poor survival in triple-negative breast cancer.•Loss of miR-146a increases the risk for post-treatment early-recurrence…”
Get full text

tRNA-derived small RNA 3'U-tRFValCAC promotes tumour migration and early progression in ovarian cancer by Panoutsopoulou, Konstantina, Magkou, Paraskevi, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Mahner, Sven, van Gorp, Toon, Braicu, Ioana, Magdolen, Viktor, Zeillinger, Robert, Avgeris, Margaritis, Scorilas, Andreas

“…INTRODUCTIONDespite recent advances in epithelial ovarian cancer (EOC) management, the highly heterogenous histological/molecular tumour background and…”
Get full text

tRNA-derived small RNA 3′U-tRFValCAC promotes tumour migration and early progression in ovarian cancer by Panoutsopoulou, Konstantina, Magkou, Paraskevi, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Mahner, Sven, van Gorp, Toon, Braicu, Ioana, Magdolen, Viktor, Zeillinger, Robert, Avgeris, Margaritis, Scorilas, Andreas

“…Despite recent advances in epithelial ovarian cancer (EOC) management, the highly heterogenous histological/molecular tumour background and patients' treatment…”
Get full text

Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer by Avgeris, Margaritis, Tsilimantou, Anastasia, Levis, Panagiotis K, Rampias, Theodoros, Papadimitriou, Maria-Alexandra, Panoutsopoulou, Konstantina, Stravodimos, Konstantinos, Scorilas, Andreas

“…Abstract In the era of precision oncology, bladder cancer (BlCa) is characterized by generic patient management and lack of personalized prognosis and…”
Get full text

The interplay between miR-1245a and BRCA2 in colorectal cancer by Scorilas, Andreas, Panoutsopoulou, Konstantina, Tsiakanikas, Panagiotis

Get full text

miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients by Panoutsopoulou, Konstantina, Avgeris, Margaritis, Magkou, Paraskevi, Mavridis, Konstantinos, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Reinthaller, Alexander, Michaelidou, Kleita, Mahner, Sven, Vergote, Ignace, Loverix, Liselore, Braicu, Ioana, Sehouli, Jalid, Zeillinger, Robert, Magdolen, Viktor, Scorilas, Andreas

“…Ovarian cancer (OC) remains a leading cause of gynecological cancer‐related death worldwide, characterized by poor 5‐year survival. Molecular markers could…”
Get full text

miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study by Panoutsopoulou, Konstantina, Avgeris, Margaritis, Mavridis, Konstantinos, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Reinthaller, Alexander, Michaelidou, Kleita, Mahner, Sven, Vergote, Ignace, Vanderstichele, Adriaan, Braicu, Ioana, Sehouli, Jalid, Zeillinger, Robert, Magdolen, Viktor, Scorilas, Andreas

“…miR-203 overexpression in ovarian tumors is associated with disease progression and worse patient’s survival, independently of FIGO stage, grade, residual…”
Get full text

tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression by Panoutsopoulou, Konstantina, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Mahner, Sven, Gorp, Toon van, Braicu, Ioana, Zeillinger, Robert, Magdolen, Viktor, Avgeris, Margaritis, Scorilas, Andreas

“…Epithelial ovarian cancer (EOC) remains a highly-lethal gynecological malignancy, characterized by frequent recurrence, chemotherapy resistance and poor 5-year…”
Get full text

Epi‐miRNAs: Modern mediators of methylation status in human cancers by Papadimitriou, Maria‐Alexandra, Panoutsopoulou, Konstantina, Pilala, Katerina‐Marina, Scorilas, Andreas, Avgeris, Margaritis

“…Methylation of the fundamental macromolecules, DNA/RNA, and proteins, is remarkably abundant, evolutionarily conserved, and functionally significant in…”
Get full text

Combined Treatment With Exenatide and Cyclosporine A or Parstatin 1-26 Results in Enhanced Reduction of Infarct Size in a Rabbit Model by Alexopoulos, Panagiotis, Panoutsopoulou, Konstantina, Vogiatzis, George, Koletsis, Efstratios, Dougenis, Dimitrios, Tsopanoglou, Nikos E

“…Exenatide and cyclosporine A have been shown to moderately protect against myocardial reperfusion injury leading to reduction of infarct size in patients. Our…”
Get full text

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming by Pateras, Ioannis S, Williams, Chloe, Gianniou, Despoina D, Margetis, Aggelos T, Avgeris, Margaritis, Rousakis, Pantelis, Legaki, Aigli-Ioanna, Mirtschink, Peter, Zhang, Wei, Panoutsopoulou, Konstantina, Delis, Anastasios D, Pagakis, Stamatis N, Tang, Wei, Ambs, Stefan, Warpman Berglund, Ulrika, Helleday, Thomas, Varvarigou, Anastasia, Chatzigeorgiou, Antonios, Nordström, Anders, Tsitsilonis, Ourania E, Trougakos, Ioannis P, Gilthorpe, Jonathan D, Frisan, Teresa

“…Chemotherapy (CT) is central to the treatment of triple negative breast cancer (TNBC), but drug toxicity and resistance place strong restrictions on treatment…”
Get full text

tRNA GlyGCC -Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression by Panoutsopoulou, Konstantina, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Mahner, Sven, Gorp, Toon van, Braicu, Ioana, Zeillinger, Robert, Magdolen, Viktor, Avgeris, Margaritis, Scorilas, Andreas

“…Epithelial ovarian cancer (EOC) remains a highly-lethal gynecological malignancy, characterized by frequent recurrence, chemotherapy resistance and poor 5-year…”
Get full text

Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer by Liu, Yueyang, Gong, Weiwei, Panoutsopoulou, Konstantina, Singer-Cornelius, Thirza, Augustin, Katharina, Bronger, Holger, Kiechle, Marion, Dorn, Julia, Scorilas, Andreas, Avgeris, Margaritis, Magdolen, Viktor, Dreyer, Tobias

“…Triple-negative breast cancer (TNBC) represents the most aggressive breast cancer subtype, associated with early metastasis and recurrence as well as poor…”
Get full text

TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity by Govers, Coen, Sebestyén, Zsolt, Roszik, János, van Brakel, Mandy, Berrevoets, Cor, Szöőr, Árpád, Panoutsopoulou, Konstantina, Broertjes, Marieke, Van, Tan, Vereb, György, Szöllősi, János, Debets, Reno

“…Adoptive transfer of T cells that are gene engineered to express a defined TCR represents a feasible and promising therapy for patients with tumors. However,…”
Get full text

CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients by Papadimitriou, Maria-Alexandra, Pilala, Katerina-Marina, Panoutsopoulou, Konstantina, Levis, Panagiotis, Kotronopoulos, Georgios, Kanaki, Zoi, Loules, Gedeon, Zamanakou, Maria, Linardoutsos, Dimitrios, Sideris, Diamantis C, Stravodimos, Konstantinos, Klinakis, Apostolos, Scorilas, Andreas, Avgeris, Margaritis

“…Bladder cancer (BlCa) is an extensively heterogeneous disease that leads to great variability in tumor evolution scenarios and lifelong patient surveillance,…”
Get full text

tRNA-derived small RNA 3'U-tRF ValCAC promotes tumour migration and early progression in ovarian cancer by Panoutsopoulou, Konstantina, Magkou, Paraskevi, Dreyer, Tobias, Dorn, Julia, Obermayr, Eva, Mahner, Sven, van Gorp, Toon, Braicu, Ioana, Magdolen, Viktor, Zeillinger, Robert, Avgeris, Margaritis, Scorilas, Andreas

“…Despite recent advances in epithelial ovarian cancer (EOC) management, the highly heterogenous histological/molecular tumour background and patients' treatment…”
Get full text

The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells by Bosch, Almudena, Panoutsopoulou, Konstantina, Corominas, Josep Maria, Gimeno, Ramón, Moreno-Bueno, Gema, Martín-Caballero, Juan, Morales, Saleta, Lobato, Tania, Martínez-Romero, Carles, Farias, Eduardo F, Mayol, Xavier, Cano, Amparo, Hernández-Muñoz, Inmaculada

“…In early stages of metastasis malignant cells must acquire phenotypic changes to enhance their migratory behavior and their ability to breach the matrix…”
Get full text